Direct coupling of annexin A5 to VSOP yields small, protein-covered nanoprobes for MR imaging of apoptosis

Contrast Media and Molecular Imaging

Volumn 9, Issue 4, 2014, Pages 291-299

  Figge, Lena ^a   Appler, Franziska ^a   Chen, Howard H ^b   Sosnovik, David E ^b   Schnorr, Jörg ^a   Seitz, Oliver ^c   Taupitz, Matthias ^a   Hamm, Bernd ^a   Schellenberger, Eyk ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Annexin A5; Apoptosis; Magnetic resonance imaging; Very small iron oxide particles; VSOP

Indexed keywords

CAMPTOTHECIN; CARBOXYLIC ACID; IRON OXIDE; LIPOCORTIN 5; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; CONTRAST MEDIUM; DEXTRAN; MAGNETITE NANOPARTICLE; MOLECULAR PROBE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOAVAILABILITY; BIOCOMPATIBILITY; COATED PARTICLE; CONTROLLED STUDY; DIMERIZATION; FEMALE; HALF LIFE TIME; HYDRODYNAMICS; IN VITRO STUDY; MOUSE; NANOPROBE; NATIVE POLYACRYLAMIDE GEL ELECTROPHORESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PH; PRIORITY JOURNAL; REPERFUSION INJURY; SYNTHESIS; T LYMPHOCYTE; TARGET ORGAN; CHEMISTRY; DIAGNOSTIC USE; GENETICS; HUMAN; METABOLISM; MOLECULAR PROBE; PROCEDURES;

ANNEXIN A5; APOPTOSIS; CONTRAST MEDIA; DEXTRANS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MOLECULAR PROBES;

EID: 84897936974     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1575     Document Type: Article

References (24)

1. Schutters K, Reutelingsperger C. Phosphatidylserine targeting for diagnosis and treatment of human diseases. Apoptosis 2010; 15: 1072-1082.
2. Kietselaer BL, Reutelingsperger CP, Heidendal GA, Daemen MJ, Mess WH, Hofstra L, Narula J. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. New Engl J Med 2004; 350: 1472-1473.
3. Kartachova M, Haas RL, Olmos RA, Hoebers FJ, van Zandwijk N, Verheij M. In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response. Radiother Oncol 2004; 72: 333-339.
4. Kratz H, Haeckel A, Michel R, Schönzart L, Hanisch U, Hamm B, Schellenberger E. Straightforward thiol-mediated protein labelling with DTPA: synthesis of a highly active 111In-annexin A5-DTPA tracer. EJNMMI Res 2012; 2: 17.
5. Yagle KJ, Eary JF, Tait JF, Grierson JR, Link JM, Lewellen B, Gibson DF, Krohn KA. Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. J Nucl Med 2005; 46: 658-666.
6. Dumont EA, Hofstra L, van Heerde WL, van den Eijnde S, Doevendans PA, DeMuinck E, Daemen MA, Smits JF, Frederik P, Wellens HJ, Daemen MJ, Reutelingsperger CP. Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation 2000; 102: 1564-1568.
7. Schellenberger EA, Bogdanov A, Petrovsky A, Ntziachristos V, Weissleder R, Josephson L. Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. Neoplasia 2003; 5: 187-192.
8. Petrovsky A, Schellenberger E, Josephson L, Weissleder R, Bogdanov A, J. Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res 2003; 63: 1936-1942.
9. Prinzen L, Miserus RJ, Dirksen A, Hackeng TM, Deckers N, Bitsch NJ, Megens RT, Douma K, Heemskerk JW, Kooi ME, Frederik PM, Slaaf DW, Zandvoort MA, Reutelingsperger CP. Optical and magnetic resonance imaging of cell death and platelet activation using annexin A5-functionalized quantum dots. Nano Lett 2007; 7: 93-100.
10. van Tilborg GAF, Vucic E, Strijkers GJ, Cormode DP, Mani V, Skajaa T, Reutelingsperger CPM, Fayad ZA, Mulder WJM, Nicolay K. Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques. Bioconjug Chem 2010; 21: 1794-1803.
11. Sosnovik DE, Schellenberger EA, Nahrendorf M, Novikov MS, Matsui T, Dai G, Reynolds F, Grazette L, Rosenzweig A, Weissleder R, Josephson L. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med 2005; 54: 718-724.
12. Schellenberger EA, Sosnovik D, Weissleder R, Josephson L. Magneto/optical annexin V a multimodal protein. Bioconjug Chem 2004; 15: 1062-1067.
13. Schellenberger EA, Bogdanov AJ, Hogemann D, Tait J, Weissleder R, Josephson L. Annexin V-CLIO a nanoparticle for detecting apoptosis by MRI. Mol Imag 2002; 1: 102-107.
14. Sosnovik DE, Nahrendorf M, Panizzi P, Matsui T, Aikawa E, Dai G, Li L, Reynolds F, Dorn GW, Weissleder R, Josephson L, Rosenzweig A. Molecular MRI detects low levels of cardiomyocyte apoptosis in a transgenic model of chronic heart failure. Circul Cardiovasc Imag 2009; 2:468-475.
15. Schellenberger E, Rudloff F, Warmuth C, Taupitz M, Hamm B, Schnorr J. Protease-specific nanosensors for magnetic resonance imaging. Bioconjug Chem 2008; 19:2440-2445.
16. Schellenberger E, Schnorr J, Reutelingsperger C, Ungethum L, Meyer W, Taupitz M, Hamm B. Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis. Small 2008; 4: 225-230.
17. Mira JP, Dubois T, Oudinet JP, Lukowski S, Russo-Marie F, Geny B. Inhibition of cytosolic phospholipase A2 by annexin V in differentiated permeabilized HL-60 cells. Evidence of crucial importance of domain I type II Ca2+-binding site in the mechanism of inhibition. J Biol Chem 1997; 272: 10474-10482.
18. Pilgrimm H. Super-paramagnetic particles with increased R1 relaxivity, process for producing said particles and use thereof. 1997, WO/1997/035200.
19. Gallagher SR. One-dimensional Electrophoresis using Nondenaturing Conditions. Current Protocols in Protein Science. John Wiley & Sons, Inc.: Brooklyn, NY, USA, 2001; Chapter 10, Unit 10.3.
20. Reynolds F, O'loughlin T, Weissleder R, Josephson L. Method of determining nanoparticle core weight. Anal Chem 2005; 77: 814-817.
21. Sosnovik DE, Garanger E, Aikawa E, Nahrendorf M, Figuiredo J-L, Dai G, Reynolds F, Rosenzweig A, Weissleder R, Josephson L. Molecular MRI of cardiomyocyte apoptosis with simultaneous delayed-enhancement MRI distinguishes apoptotic and necrotic myocytes in vivo: potential for midmyocardial salvage in acute ischemia. Circul Cardiovasc Imag 2009; 2: 460-467.
22. Lewit-Bentley A, Morera S, Huber R, Bodo G. The effect of metal binding on the structure of annexin V and implications for membrane binding. Eur J Biochem 1992; 210:73-77.
23. van Genderen HO, Kenis H, Hofstra L, Narula J, Reutelingsperger CPM. Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization. Biochim Biophys Acta 2008; 1783: 953-963.
24. Koh I, Hong R, Weissleder R, Josephson L. Nanoparticle-target interactions parallel antibody-protein interactions. Anal Chem 2009; 81: 3618-3622.